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Today’s life style has completely changed by all the 
means our diet pattern, life styles and behavioral 
pattern  which  has  made  man  the  victim  of  many  
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diseases. Sthaulya (obesity) is one among them. 
Sthaulya is one of the most effective disease which 
affect someone social, physical and mental features. 
As per modern view, it is a precursor to coronary 
heart disease, high blood pressure, diabetes melitus 
and osteoarthritis which have been recognized  as the 
leading killer diseases of the millennium.
[1]
 All these 
disorders are an indication of the failing systems, their 
inability to provide optimum performance to upkeep 
the physiological clock ticking. 
In Ayurveda, Sthaulya has been described by Acharya 
Charaka as one of the eight despicable persons 
(Ashtaunindita) in the context of the body.
[2] 
Principles of Ayurveda have significant value even in 
the life of modern man. The reason behind this is, life 
is the underlying theme over which the whole science 
of Ayurveda is interwoven. Hence one cannot deny 
A B S T R A C T  
Sthoulya is one of the most effective disease which affects someone social, physical and mental 
features. As per modern view, it is a precursor to coronary heart disease, high blood pressure, 
diabetic mellitis and osteoarthritis which have been recognised as the leading killer diseases of the 
millennium. Sthoulya is a state of increased Vikruta Vruddhi of Medodhatu. It is one of the 
Santarponottha Vikaras where a physician needs to apply the principle of Vishesha which can restore 
the unhealthy increase of components to the previous undiseased form.  The drug Haritaki and 
Amalaki are having Laghu and Rooksha Guna which are opposite Gunas to that of the Sthoulya. 
Objectives -  Practical evaluation of the Sthaulyahara effect of Haritaki and Amalkai based on the 
principle of Hrasa Hetur Visheshascha. Results - 60 patients (92%) had completed the trial, no 
adverse effect were reported. Both the groups had improved in the clinical trials, overall statistical 
significance was observed in the scores of both the groups. Discussion - By this statistical result we 
can concluded that Group A patients were more releived than Group B who were administered Haritaki 
Choorna. The hypothesis decided for the study was ‘Vishesha’ is the prime cause for Hrasa. Here it 
was clear that Vishesha applied was Guna Vishesha. Here significant results itself shows that Vishesha 
has done its role in reducing the obesity (Hrasa) in better way in both the Groups.  
Key words: Vishesha, Sthoulya, Obesity, BMI, Haritaki, Amalaki. 
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the implicability of these principles. The principles of 
Ayurveda are based on strict experimental studies of 
several years. These principles are the outcome of 
those studies. Several Acharyas have tested these 
principles for many years and then these principles 
have got a place in Ayurvedic Samhitas. 
Sthaulya is a state of increased Vikruta Vruddhi of 
Medodhatu. It is one of the Santarpanottha 
Vikaras
[3]
where a physician needs to apply the 
principle of ‘Vishesha’, which can restore the 
unhealthy increase of components to the previous 
undiseased form.
[4] 
Since Samhitakala Sthaulya is well a known 
Krcchrasadhya Vyadhi. It can be betterly managed by 
applying the concept of ‘Hrasahetur Visheshacha’, as 





 has Laghu and Ruksha Guna and 
Amalaki
[7]
 is having Kaphagna property which are 
opposite Gunas to that of the Sthaulya. 
Hence the present research work was planned to 
evaluate the concept of  ‘Hrasahetur Visheshascha’ 
and also compare the clinical effect of Haritaki and 
Amalaki in Sthaulya (Obesity).  
OBJECTIVE OF THE STUDY 
Practical Evaluation of the Sthaulyahara effect of 
Haritaki and Amalaki based on the principle of 
Hrasahetur Visheshascha. 
MATERIALS AND METHODS 
Drug Source 
The medicines required for the present study were 
procured from the Pharmacy of BLDEA’S AVS 
Ayurveda Mahavidyalaya, Vijayapur, Karnataka. 
Clinical Source 
Patients of either sex diagnosed to be suffering from 
obesity were selected from OPD and IPD of BLDEA’s 
AVS Ayurveda Mahavidyalaya Hospital, Vijayapur. 
Method of collection of data 
A special proforma was prepared with details of 
history, physical signs and symptoms mentioned for 
the Sthaulya. Patients were analyzed and selected 
accordingly. A viable and indigenously designed 
method was used to assess the parameters of signs 
and symptoms. 
Study Design: Randomised Single Blind Comparative 
Clinical Study. 
Sample Size: Total number of patients taken for the 
study will be 60 including dropout. 
Duration of treatment: 30 days 
Duration of follow-up: 15 days 
Study Duration 
 Total study duration: 45 days 
 Treatment duration:  30 days 
 Follow up duration: 15 days 
Inclusion Criteria 
1. Patients diagnosed as Sthaulya having classical 
signs and symptoms will be selected. 
2. Patients of either sex in between age group 20 - 
60 years. 
3. Patients with BMI more than 25  
Exclusion Criteria 
1. Patients age less than 20 and more than 60 years. 
2. Patients having major systemic disorders or other 
illnesses which interfere with the present study. 
3. Patients of  Sthaulya with its severe complications 
like Cerebral vascular diseases, Ischemic heart 
diseases will be excluded. 
Diagnostic Criteria 
1. Diagnosis will be made based  on classical signs 
and symptoms like Spik, Sthana and Udara 
Lambana (increased fat deposition in chest, 
abdomen and gluteals) 
2. Atisweda, Atikshudha and Atitrishna. 
3. Kshudra Shwasa (breathing difficulty) and 
Daurbalya (weakness) 
4. Patients having BMI more than 25. 
Assessment Criteria 
Assessment will be done based on objective and 
subjective criteria before, during and after treatment.  
Subjective Criteria 
1. Dourbalya (general weakness) 
2. Swedabadha (excessive sweating) 
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3. Kshudhatiyoga (excessive hunger) 
4. Pipasaatimatram (excessive thirst) 
Objective Criteria 
1. Calculation of BMI (Weight in kg divided by height 
in meter square) 
2. Waist Hip circumference ratio 
3. Circumference of chest, abdomen, mid arm and 
mid thigh. 
4. Lipid profile (12 hours fasting)  
Laboratory Investigations 
1. Urine routine (Albumin, Sugar and micro)  
2. Blood routine (Hb, TC, DC) 
3. Lipid profile (12 hours fasting) 
4. Serum total cholesterol, Serum triglycerides, Low 
density lipoproteins, High density lipoproteins, 
VLDL and HDL: Cholesterol ratio. 
Drug and Posology 
Group A: Haritaki Churna                       
 Dosage: 6 g / b.i.d. 
 Anupana: Ushna Jala 
 Route: Oral 
 Duration: 30 days  
 Follow up: 15 days 
Group B: Amalaki Churna 
 Dosage: 6 g / b.i.d. 
 Anupana: Ushna Jala 
 Route: Oral 
 Duration: 30 days  
 Follow Up: 15 days   
OBSERVATIONS AND RESULTS 







20-30 12 13 25 41% 
30-40 11 13 24 40% 
40-50 5 3 8 13% 
50-60 3 1 4 6% 
The maximum number of patients are from 20-30yrs 
and 30-40 yrs. This shows middle age peoples are 
more prone to Sthaulya. 
Table 2: Medhavaha Srotas wise distribution of 65 






Javoparodha 2 1 3 4% 
Daurbalya 25 28 53 81% 
Daurgandhya 14 11 25 38% 
Swedabhadha 15 12 27 41% 
Angashaithilya 21 21 42 64% 
Snigdhangata 17 12 29 44% 
Alasya 28 28 56 86% 
Pippasatimatra 22 16 38 58% 
Mutrasada 2 0 2 3% 
Talushosha 21 17 38 58% 
Kanthamukhash
osha 
8 9 17 26% 
Bahu Mutra 6 4 10 15% 
Spik Sthana 
Udara Chalatwa 
28 21 49 75% 
Ati Slakshna 2 4 6 9% 
Among 65 patients Kanta Mukha Shosha 75%, Alasya 
86%, Pipasatimatra and Talushosha 58%, Dourbalya 
81%, Swedapravrutti 41%, Angashaithilya 64% 
symptoms patients were suffering from Sthaulya. 
Table 3: Nidanawise (Aharatmaka) distribution of 65 






Athisampoorna 17 16 33 50% 
Adhyshana 6 5 11 16% 
Guruaharaseva
na 
28 22 50 76% 
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14 18 32 49% 
Sheeta Ahara 
Sevana 
26 25 51 78% 
Snigdha Ahara 
Sevana 
21 18 39 60% 
Gramybha 
Ahara Sevana 
9 8 17 26% 
Phala Sevana 6 12 18 27% 
Navamadhya 
Sevana 
3 4 7 10% 
Auduka Sevana 9 6 15 23% 
Ksheera Sevana 8 12 20 30% 
Shali Sevana 25 27 52 80% 
Bhojanotar 
Sheet Jala Pana 
20 19 39 60% 
Among 65 patients, 80% are Shali Sevana, 78% are 
Sheeta Ahara Sevana, 76% are Guruaharasevana, 
Bhojana Nantara Sheeta Jala Sevana 60%, 
Atisampoorna 50%, Snigdha Ahara Sevana 60%, 
Snigdha Ahara Sevana 60% these are the main Nidana 
which are cause for the Sthaulya. 
Table 4: Nidanawise (Viharatmaka) distribution of 65 






Avyayama 27 25 52 80% 
Avyavaya 16 13 29 44% 
Diwaswapna 5 12 17 26% 




6 11 17 26% 
Bhojanotar 
Snana 
1 6 7 10% 
Bhojanotar 
Nidra 
24 25 49 75% 
Among 65 patients, 80% are Avyayama, 75% are 
Bhojanotar Nidra, 47% are Asanasukha, 44% are 
Avyavaya, 26% are diwaswapna and Gandha 
Malayanu Sevana, 10% are Bhojanotar Snana. 
Effect of therapy in Group A 
In this group total 62 patients were registered out of 
which 2 patients were dropped out while remaining 
30 patients have completed the full course of 
treatment. Here the effect of drug Haritaki Churna on 
various parameters is presented in the following 
tables.  
Table 5: Effect on subjective and objective criteria 
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In Kshudra Shwasa 86%, Angashitilya 87% and 
Gatrasada 86% relief was recoreded which is 
statistically significant (<0.0001), in Anga Gaurava  
77%, Swedapravrutti 76%, Alasya 74 %, Chala Sphik  
Stana Udara 71%, Snigdhangata 70 %, Dourbalya 
69%, relief were recorded and in Nidra 47%, Jarana 
Shakti 20%  relief was recorded which is statistically 
significant (<0.0001), Pipasa 30% Daurgandhya 54%, 
Atikshudha 2.3% , Alpa Vyayaya 0% relief is recorded 
which is statistically insignificant. 
















































































































































































Weight reduction 3.02% relief found which is 
statistically highly significant(p<0.0001) in BMI 2.929% 
relief found which is statistically highly significant. 
Relief was found which is highly significant (<0.0001), 
chest circumference 1.1804 relief found which is 
statistically highly significant (<0.0001), waist 
circumference 0.7036 relief found which is  very 
statistically significant (0.0014) hip circumference 
1.0963 relief found, abdominal circumference 1.096% 
relief were found  which is consider as non significant 
(0.0004), (0.0003), in chest circumference 1.1804% 
relief were found which is highly statistically 
significant (<0.0001) mid arm 0.9 % and mid thigh 
circumference 2.02%  relief were found which is not 
statistically significant.  





































Dr. Shruti Hiremath et.al. Clinical evaluation of the Sthaulyahara effect of Haritaki and Amalaki. 
ISSN: 2456-3110                                                    ORIGINAL ARTICLE May-June 2018 
 




































































































































































































Eosinophil  count 26 %, Monocyte count 72.7 % , 
Haemoglobin count 6.72% , Serum cholesterol (LDL) 
26.65 %, Serum cholesterol (VLDL) 26.23% , Serum 
Trigylcerides 20.02 %, Serum total cholesterol 18.96 % 
relief were recorded which is highly statistically 
significant(<0.0001). WBC count 6.56 % , Neutrophils 
Count 5.53 % , Serum Cholesterol (HDL) 3.80 % relief 
were found which is statistically insignificant. 
Effect of therapy in Group B 
In this group 63 patients were registered out of which 
3 patients have dropped out and 30 patients have 
completed the full course of treatment. Here the 
effect of Amalaki Churna on various subjective and 
objective parameters is as follow . 
Table 8: Effect on subjective and objective criteria 



























































































































































































Erection 2.5 2.5 0 0 0 0 0 1.00
0 
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In Chala Sphik Stana Udara Lambana 59 %, Dourbalya 
61.7%, Sweda Pravrutti 70%, Jarana Shakti 17 %, 
Pipasa 43 %, Alpa Vyavaya 14.4 % relief was found 
which is statistically highly significant. In Kshudra 
Shwasa 81%, Atikshudha 0.86%, Abhyavarana Shakti 
3.7 % relief was found which is statistically 
insignificant.  










































































































































































In weight reduction 3.67% relief was found which is 
extremly significant in BMI  3% were get relief which is 
extremely statistical significant, waist circumference 
0.155461% got relief and which is statistically 
insignificant. Hip circumference 0.2302%  relief was 
found which is statistically insignificant, chest 
circumference 1.192% releif was found which is 
statistically  insignificant. 
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Haemoglobin  count 7.52% , Serum Cholesterol  (LDL) 
23.94 %, Serum Cholesterol  (VLDL) 35.73%, Serum 
Triglycerides 35.92 % , Serum total Cholesterol 
17.144% relief  was  found which is statistically highly 
significant . WBC count 12 % , Neutrophils count 10%, 
Eosinophil count 20 %, Lymphocyte count 16.7%, 
monocyte count 115 % , Serum cholesterol (HDL) 
0.85% relief was found which is statistically 
insignificant. 







Cured 3 4 7 10% 
Markedly. 
Imp 
5 6 11 16% 
Moderately. 
Imp 
12 12 24 26% 
Mild.Imp 8 5 13 20% 
Unchanged 2 3 5 7% 
DISCUSSION 
It is the necessity of time to refurbish the principles of 
Ayurveda in today's context. It is not sufficient to 
prove these principles conceptually but it should be 
supported by some clinical data. These principles 
cannot be accepted if they are not supported with 
clinical observations. Clinical study gives authenticity 
to such principles. It is already said that the study was 
undertaken to prove the principle 'Hrasa Hetur 
visesasca' clinically. The hypothesis decided for the 
study was Vishesha is a principle cause for Hrasa 
(Diminution). To prove this hypothesis a clinical study 
was performed in the patients of Sthaulya. Here 
Sthaulya is taken for the study because in Sthaulya 
there is abundant growth of Medodhatu in the body 
which is having Prthvi and Apa Mahabhuta 
dominance. It is a condition of Vrddha Medodhatu. 
So, it requires the drug which can cause Hrasa 
(diminution) of Medodhatu for its cure. As per the 
hypothesis of this study, this is the unique condition 
to apply Vishesha. Vishesha applied for this study was 
Haritaki and Amalaki. Both are having Kaphagna and 
Medoghna properties due to Agni and Vayu 
Mahabhuta dominance in them. So, it was thought at 
that time that being a Vishesha for Medhodhatu, 
Haritaki will cause Hrasa of increased Medodhatu in 
Sthula patients .  
In present study it was observed that most of the 
patients i.e. 41%  were from the age group of 20 to 30 
years, 40% were from age group of 30-40 yrs. Modern 
textbooks also supports the same observations i.e. 
Excess weight gain usually starts when individuals are 
aged between 20 and 40 years with maximum body 
weight being achieved in middle age.
[8]
 The reason 
behind this observations might be that as the age 
progresses person are not changing their dietic habits. 
As the age progress energy expenditure reduces but 
food intake providing energy remain the same. It 
leads to storage of excess energy in the form of fat, 
which leads to Sthaulya (Obesity). 
In this study almost 80% patients were females. In 
young women, body fat stores may be below 30 
percent and increase gradually to more than 35 
percent in older women whereas in men it increases 
upto 25 percent only. In every region the prevalence 
of Obesity is higher among women then among men 
(Oxford's textbook of Medicine). The reason behind 
this observation might be the feminine factors like 
puberty, menstrual disturbances, menopause, post 
operative and oral contraceptives. 
In this study maximum number of patients (73%) were 
married. This might be due to the middle age in which 
a person remains married. The reason behind this 
might be light nature of work, advancement of new 
techniques, tools (eg. Mixtures, washing machines) 
which reduces energy expenditure and besides these 
the most important cause is Diwaswapna. 78% 
patients were from middle class (S/E status). 18 % 
patients were from higher class. From this 
observation it cannot be said that Sthaulya has 
dominance in Middle class. In the present study 75 % 
patients were sedentary occupation, 23% patients 
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were active occupation it shows sedentary occupation 
people more prone to Sthaulya. In the present study 
95% patients get gradually increase of weight, 3% 
patients get insidious weight gain and 3% patients got 
rapid weight gain. It shows  the time of onset of 
weight gain is gradually increased. In the present 
study 76% patients were of Kapha Pitta Prakriti and 
23% patients were of Kapha Vata Prakrti. It shows the 
dominance of Kaphadosha in Prakriti, which is the 
most conductive one for Sthaulya. The study points 
out that involvement of Kapha Dosa playing very 
important role in Sthaulya. Most of the patients from 
the present study were having their weight between 
60 to 80 kg. As the selection criteria of patients itself 
shows selection of overweight patients only. In this 
study maximum number of patients were found to 
have Mandagni. Obstructed Vatadosa due to 
Medodhatu leads to Tiksnagni, which is the major 
consequence of Sthaulya. Due to this Tiksnagni, 
whatever a person eats is digested in short time and 
patient demands for more food again and again. This 
might be due to Tiksnagni condition which manifests 
in the form of symptoms like increased 
Abhyavaharana and Jaranasakti. Maximum number 
of patients in the present study were i.e. 55% were 
Vegetarians, 38% patients were mixed. This 
observation reflects the predominant diet of this 
region which is vegetarian followed by local 
population. Vegetarian diet enriched with extra oil, 
butter, ghee, milk products causes production of extra 
fat which leads to conditions like Sthaulya.  
Observations from clinical study shows the Madhura 
87%, Amla 13% and Lavana Rasa 1%, Katu 98% 
consuming tendency of the patients. All the patients 
possessing Katu Rasa Dravyas are not prone to 
Sthaulya, in this study patients of this region used to 
consume more Katu Dravyas. As well as over 
indulgence of the patients in the diet having Guru 89 
%, Sheeta 26% and Snigdha Guna 58% dominance. 
This is evidenced in classics as well as in previous 
studies that these are Medovriddhikar factors which 
ultimately leads to Sthaulya.  
Maximum number of patients i.e. 25% were found to 
be doing moderate type of work followed by 75% who 
were doing sedentary type of work.  In classics 
Acharyas have stated that causative factors like 
Avyayama, Cestadvesa, Asanasukha etc. Are the 
principles causes of Sthaulya.  Maximum number of 
patients i.e. 72% were found to have sound sleep and 
27% patients were having good sleeping hours as 6-8 
hrs/day.  Henceforth, sound sleep persons are more 
prone to Sthaulya. As it is stated in classics also that 
patients of Sthaulya are having Kapha dominant 
Sharira Prakrti and Tamas dominant Manasprakrti, so 
it is obvious that maximum number of patients should 
have sound sleep. This shows good prognosis of the 
disease. 
Aharatmaka Nidanas were found in maximum 
number of patients as evidenced in classics. All these 
Nidanas were having Kapha Medovriddhikar 
properties and owing to these properties they 
increase Kapha and Meda in the body. Viharatmaka 
Nidanas reported in the present study were also as 
per classics. The combine effect of all these Nidanas is 
reduction in energy expenditure and increase in 
energy gain which ultimately disturbs the balance and 
leads to Sthaulya. 
All the patients were selected for this study, after 
assessing the selection criteria for Sthaulya, so it is 
obvious that all the patients should have complaint of 
Bharvrddhi. 100% patients were found to be suffering 
from Angagauravata. The reason behind this is, 
Medodhatu is having Prthvi and Aap Mahabhuta 
dominance, so abundant growth of Medodhatu in 
Sarira leads to increase of Gunas like Guru, Seeta, 
Snigdha in the body, which ultimately leads to 
Angagauravata. It is also said in classics that 
Medodhatu produced in Sthaulya condition is in 
Amavastha which causes Angagauravata. In Sthaulya, 
Medodhatu obstructs the normal path of Vatadosa, 
this Vatadosa (Samana Vayu) stimulates the Pachaka 
Pitta in the Kostha which leads to symptom like 
Atiksudha. Sweda is said to be Mala of Medodhatu, 
increased production of Medodhatu increases 
Swedapravrtti of the body. This increased 
Swedapravartuna might be the reason behind 
Atipipasa.  
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Better results were found in symptoms like Atiksudha 
and Atinidra in  both group A  and  group  B. Due to 
this reason symptom like Atiksudha were found to 
have better results. This is also evidenced in classics 
that Haritaki with its own properties can do the 
function of Strotovibandhanasana. 
In Kshudra Shwasa 86% in group A and 81% patients 
were relieved in group B.  in Chala Sphik Stana Udara 
71% in group A and 59% in group B were relieved. In 
dourbalya 69% in group A and 61% in group B were 
relieved. In Sweda Pravrutti 76% in group A and 70% 
in group B were relieved. In Dourgandhya 54% in 
group A and 84% in group B were relieved.  In 
Atikshudha both group 0.8% patients were relieved. In 
Abhyavarana Shakti 2.3% in group A and 3.7% in 
group B were relieved. In Jarana Shakti 20% in group 
A and 17% in group B were relieved . In Pipasa 30% in 
group A and 43% in group B were relieved. In Alpa 
Vyavaya 14% group B were relieved. In Nidra 47% in 
both group patients were relieved. In Alasya 74% 
patients of group A and 71% in group B were relieved. 
In Snigdhangata 70% in group A and 69% in group B 
were relieved. In Anga Gourava 77% in group A and 
69% in group B patients were relieved. In Gatrasada 
86% in group A and 66% in group B were relieved. In 
Angashaithilya 87% in group A and 84% in group B 
were relieved. 
In BMI 2.92% in group A , 3.63% in group B waist 
circumference 0.70% in group A and 0.155% in group 
B , Hip circumference 1.2 4% in group A and 0.23% in 
group B . In Abdominal circumference 1.09% in group 
A and 1.13% in group B. In chest circumference 1.18% 
in group A and 1.19% in group B . In Mid arm 0.98% in 
group A and 1.89% in group B. Mid thigh 
circumference 2.02% in group A and 1.37 in group B . 
weight 3.02% in group A and 3.67% in group B . By this 
statistical data we can depict or conclude that group A 
is highly significant in reducing the BMI in all 
circumference as compared to group B .  
In Medovaha Srotas  the prominent symptoms are 
Alasya 86%, Dourbalya 81%, Sphik Stana Udara 
Chalatwa 75%, Snigdhangata 44% , Angashaithilya 
64%, Pipasa Atimatra 58%, Talushosha 58%, 
Swedabadha 41%, Dourgandhya 38%, Kantashosha 
26%, Bahumutrata 15%, Javoparodha 4%, 
Atishlakshna 9%, Mutrasada 3%. 
CONCLUSION 
By this statistical result we can conclude that Group A 
patients were more relieved than group B who were 
administered Haritaki Churna. Nidanas of Sthaulya 
mentioned in classics are now changing. Increasing 
stress, faulty dietary habits and decreased awareness 
regarding exercise are becoming the prominent 
causative factors for Sthaulya. The drug Haritaki and 
Amalaki shows better results on the objective 
parameters realted to obesity (i.e. body weight, BMI, 
body circumference) which shows depletory action. 
The hypothesis decided for the study was 'Vishesha' is 
the prime cause for Hrasa. Here it is clear that 
Vishesha applied were Guna Vishesha.  Here 
significant result itself shows that Vishesha has done 
its role of Hrasa in betterway. 
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